Endometriosis Therapeutics Market to Be Dominated by Hormonal Therapy Segment Through 2027
Growing awareness about
women's health problems and the development of non-invasive diagnostics methods
are expected to drive the demand for Endometriosis Therapeutics Market in the
forecast period, 2023-2027.
According to TechSci Research
report, “Endometriosis Therapeutics Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2017-2027”, The global endometriosis
therapeutics market is anticipated to grow at impressive rate in the forecast
period, 2023-2027. The increasing cases of chronic disease and rising demand
for advanced healthcare are driving the market share. The rapid growth of the
population, the growing pervasiveness of gynecological and chronic diseases, an
increasing number of people who have endometriosis, ongoing R&D activities
for advanced endometriosis treatment, and rising demand for hormonal therapies
& novel drugs are other reasons for the market growth. As per WHO, more
than 190 million reproductive women and girls will die from endometriosis
worldwide in 2030. Now, peoples are concerned about women's health and visit
doctors and consultants for proper treatment. Therefore, the demand for
endometriosis therapeutics is expected to increase significantly in the
projected period.
Many women worldwide
suffer from endometriosis and take treatment from consultants and doctors. As
they are getting a good outcome, they are suggesting the therapy to other
patients, and this trend will increase the market growth. Many initiatives are
run by the government, NGOs, and agencies for women's health upliftment. Thus,
the abovementioned factors will drive the development, directly influencing the
expansion of endometriosis therapeutics.
Browse over XX market
data Figures spread through 110 Pages and an in-depth TOC on " Endometriosis Therapeutics Market "
The global
endometriosis therapeutics market is segmented based on endometriosis type,
diagnostic method, therapeutic method, distribution channel, and end-user.
Based on the drug
category, the market is divided into oral contraceptives, progestins, NSAIDs,
GnRH analogues, and others. The oral contraceptives segment is expected to hold
the largest market share in 2022. Oral contraceptives are a conventional method
for treating endometriosis and are available in every country. Due to the
reason as mentioned above, the demand for Oral contraceptives is highest in
their segment. In this segment, there is some drawback to which technological
advancement is going on to reduce its side effect.
Based on
Treatment Method, the market is split into hormonal therapy and pain
management. As per estimates, the hormonal therapy segment is going to
experience the highest market share leaving its competitor during the forecast
period. Due to its trait, it enhances its effectiveness and reduces the risk of
cancer; doctors and acceptable by patients mostly recommend it.
Based on
end-user, the market is divided into hospitals & clinics, ambulatory care
centers, and others. Hospitals & clinics are expected to account for a
significant market share over the next projected years. The highest number of
anticipated customer footsteps lies in this segment as any patient suffering
from vital or non-crucial problems visits hospitals & clinics for
consultancy. Customers who are facing the problem need mental as well as a
medicinal treatment, and here they can receive both treatments.
Major
operating companies operating in global endometriosis therapeutics market are:
·
Abbott Laboratories,
Inc.
·
AbbVie, Inc.
·
Bayer AG
·
Pfizer, Inc.
·
Ipsen SA
·
Evotec SE
·
Myovant Sciences
Ltd.
·
Philogen S.p.A.
·
Astellas Pharma Inc.
·
Orphagen
Pharmaceuticals, Inc.
·
Medical Gas
Solutions Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
"The North American
region is expected to dominate the market due to its awareness program and
people's concern towards women's healthcare. The Asia-Pacific region is
expected to dominate the market in the upcoming period due to its increasing
women population and vigilant people. Demand for advanced healthcare will
increase spending on endometriosis therapeutics by governments and individuals,
propelling the market share of Endometriosis Therapeutics in this region. In
2022, Australia has funded 58 million for improving endometriosis under the
national action plan. Apart from these, the National action plan. Janani Shishu
Suraksha Yojana, the National action plan, Women's health alliance are
different initiatives by the government for the upliftment of women's health.
According to the WHO report, in 2021, almost 190 million reproductive women and
girls will be affected by endometriosis worldwide. This awareness or number of
spending indicates an increase in market share. Additionally, growing awareness
about endometriosis can positively impact the market share.
Market players are proposing
novel transdermal drug delivery technologies such as topical applicators to
overcome the side effects of oral contraceptives and improve efficiency.
Innovation, expansion, and R&D practices by manufacturers & marketers
for expanding & reach a new customer base with impact market growth and
create favorable conditions to boost the global endometriosis therapeutics
market growth till 2027.” said Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management consulting firm.
Endometriosis
Therapeutics Market- Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2017-2027 Segmented By Endometriosis Type (Superficial Peritoneal
Lesion, Endometrioma, Deeply Infiltrating Endometriosis Therapeutics), By
Diagnostic Method (Ultrasound, Pelvic Examination, Laparoscopy, Magnetic
Resonance Imaging, And Others), By Treatment Method (Hormonal Therapy, And Pain
Management), By Drug Category (Oral Contraceptives, Progestins, NSAIDs, GnRH
Analogues, And Others), By Diagnostics Type (Pure Medical Imaging, And General
Laboratory Use), By Distribution Channel ( Retail Pharmacies, Hospital
Pharmacies, Online Pharmacies), By End-User, (Hospitals & Clinics, Ambulatory
Care Center, And Others), By Company, By Region, has evaluated the future growth
potential of global endometriosis therapeutics market and provides statistics
& information on market size, structure, and future market growth. the
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global endometriosis therapeutics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com